Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Screening for Gonorrhea and Chlamydia Affect the Incidence of These Infections in Men Who Have Sex With Men Taking HIV Pre Exposure Prophylaxis (PrEP): a Randomized, Multicentre Controlled Trial

NCT04269434 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT04269434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04269434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Screening for Gonorrhea and Chlamydia Affect the Incidence of These Infections in Men Who Have Sex With Men Taking HIV Pre Exposure Prophylaxis (PrEP): a Randomized, Multicentre Controlled Trial
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Not applicable
Overall status
Completed
Start date
September 21, 2020
Completion date
August 31, 2022
Enrollment
1,014 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chlamydia trachomatis infection, neisseria gonorrhoeae infection